Fig. 1 | Hypertension Research

Fig. 1

From: Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease

Fig. 1

The association between diagnosis of metabolic dysfunction associated fatty liver disease (MAFLD) with hypertension was greater than the associations with diagnoses of fatty liver (FL) and non-alcoholic fatty liver disease (NAFLD). CCL2 Chemokine C-C motif ligand 2; IL-6 interleukin-6; ROS reactive oxygen species; TNF-α tumor necrosis factor-α

Back to article page